These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9169664)

  • 21. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor.
    Massicotte P; Marzinotto V; Vegh P; Adams M; Andrew M
    J Pediatr; 1995 Sep; 127(3):389-94. PubMed ID: 7658268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency.
    Davidson SJ; Turner N; Tillyer L
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):707-8. PubMed ID: 20885134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery.
    Okabayashi S; Ogawa S; Tanaka KA; Nishiyama T; Takeshita S; Nakayama Y; Nakajima Y; Sawa T; Mizobe T
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic monitoring of warfarin: the appropriate response marker.
    Costa IM; Soares PJ; Afonso M; Ratado P; Lanaot JM; Falcão AC
    J Pharm Pharmacol; 2000 Nov; 52(11):1405-10. PubMed ID: 11186249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
    Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the international normalized ratio levels obtained by portable coagulometer and laboratory in a clinic specializing in oral anticoagulation.
    Meneghelo ZM; Barroso CM; Liporace IL; Cora AP
    Int J Lab Hematol; 2015 Aug; 37(4):536-43. PubMed ID: 25754527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
    Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
    Sanfelippo MJ; Sennet J; McMahon EJ
    WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of warfarin therapy monitored by the International Normalized Ratio versus the prothrombin time ratio.
    Andrews TC; Peterson DW; Doeppenschmidt D; Foster JS; Lucca MJ; Deering JA; LaVeau PJ
    Clin Cardiol; 1995 Feb; 18(2):80-2. PubMed ID: 7720294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry.
    Nakamura A; Ago T; Kamouchi M; Hata J; Matsuo R; Kuroda J; Kuwashiro T; Sugimori H; Kitazono T;
    Stroke; 2013 Nov; 44(11):3239-42. PubMed ID: 23963334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A prospective study of oral anticoagulation therapy monitored with the P&P-test.].
    Haraldsson M; Onundarson PT; Gudmundsdottir BR; Einarsdottir KA; Kristinsson A; Palsson K; Petursson MK
    Laeknabladid; 1998 Jan; 84(1):32-40. PubMed ID: 19667428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin.
    Onundarson PT; Arnar DO; Lund SH; Gudmundsdottir BR; Francis CW; Indridason OS
    Int J Lab Hematol; 2016 May; 38 Suppl 1():78-90. PubMed ID: 27426862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
    Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
    Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical derivative applied to international normalised ratio and analytical variations in oral anticoagulant therapy control.
    Introcaso G; Cuboni A; Ratto A; Foieni F
    Haemostasis; 2000; 30(6):281-9. PubMed ID: 11356996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring warfarin therapy with the international normalized ratio.
    Howard PA
    Ann Pharmacother; 1994 Feb; 28(2):242-4. PubMed ID: 8173144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
    Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
    Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
    Harder S; Graff J; Klinkhardt U; von Hentig N; Walenga JM; Watanabe H; Osakabe M; Breddin HK
    Thromb Haemost; 2004 Jun; 91(6):1137-45. PubMed ID: 15175800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.